Capsule Summary Slidesets

Share

Program Content

Activities

  • STOP
    STOP Study: Incidence and Predictors of ALT Flares in HBeAg-Negative Patients Discontinuing NA Therapy for CHB
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2019

    Expires: April 13, 2020

  • US HCV Care Cascade
    Retrospective Analysis Identifies Numerous Gaps Along HCV Care Cascade Across Physician Specialties in the US
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2019

    Expires: April 13, 2020

  • HCV/HBV Test-and-Treat
    Pilot Study of Same-Day Testing and Treatment of HCV and HBV in Egyptian Village
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2019

    Expires: April 13, 2020

  • ETHOS Engage
    ETHOS Engage Study: Uptake of HCV Testing and Treatment Among People Who Inject Drugs in Australia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2019

    Expires: April 13, 2020

  • SMART-C
    SMART-C: Standard vs Simplified Monitoring of Initial HCV Treatment With Glecaprevir/Pibrentasvir
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 15, 2019

    Expires: April 13, 2020

  • English HCV Registry
    Efficacy of HCV Treatment in a Large Clinical Cohort From the English National HCV Registry
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 16, 2019

    Expires: April 14, 2020

  • REGENERATE
    Interim Analysis of Phase III REGENERATE: Obeticholic Acid vs Placebo for NASH
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 16, 2019

    Expires: April 14, 2020

  • Emricasan NASH Cirrhosis and Portal Hypertension
    Phase II Trial of Emricasan in NASH Cirrhosis and Severe Portal Hypertension
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 17, 2019

    Expires: April 15, 2020

  • HCC Risk With TDF vs ETV in CHB
    Lower Risk of Hepatocellular Carcinoma With TDF vs ETV in Patients With Chronic Hepatitis B From Large Hong Kong Database Analysis
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 17, 2019

    Expires: April 15, 2020

  • VK2809 in NAFLD
    Randomized Phase II Trial of VK2809, an Investigational Thyroid Hormone Receptor Agonist, vs Placebo in NAFLD With Hyperlipidemia
    Conference Coverage
    Slideset Download
    Congratulations: You achieved a completion on 04/09/2022

    Released: April 22, 2019

    Expires: April 20, 2020

Provided by

ProCE Banner

Supporters

AbbVie

Gilead